Search

everythinglearnresearchcommunity

for

Search:↓

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

Cernitin™, a pollen extract, was found to significantly reduce pain and inflammation in rats with chronic prostatitis, suggesting it could be a useful alternative to certain anti-inflammatory drugs.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

Plant extracts like Avicennia marina, Boehmeria nipononivea, and Camellia sinensis could potentially treat hair loss with fewer side effects than synthetic drugs.

Exposure to low doses of finasteride in the womb causes changes in the prostate of both male and female gerbils.

Unripe Rubus occidentalis extracts may help treat benign prostatic hyperplasia.

Bone mineral and minocycline boost bone cell growth, aiding healing.

Precise objectives can improve student achievement in health education.

Some treatments for hereditary hair loss are effective but vary in results and side effects; new therapies show promise but need more research.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Testosterone, progesterone, and levonorgestrel change enzyme levels related to fat production in hamster skin, which could affect skin oil and acne.

Epigenetic changes might protect occipital hair from male pattern baldness.

Generalized glucocorticoid resistance causes hormone imbalances and varied symptoms due to gene mutations.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Hormones, especially androgens, play a key role in causing acne, and treatments like hormone control pills and hormone-blocking medications can help.

Bicalutamide may effectively treat female pattern hair loss with minimal side effects.

Anabolic-androgenic steroids are dangerous and educating people about their risks is essential.

Noni fruit extract, specifically the FEA-3 sub-fraction, can increase hair growth and reduce baldness in male rabbits, potentially acting like common hair loss treatments.

The contraceptive implant Implanon may be linked to hair loss, but the reported case of alopecia could be unrelated to the implant.

No significant hormone differences found in postmenopausal women with androgenetic alopecia.

Targeting androgen receptors in the skin is the most effective treatment for hyperandrogenism-related skin issues.

Biochanin A from soy is a promising and safe candidate for treating hair loss.

Biochanin A from soy is a promising and safe candidate for treating hair loss.

Sper-12 nanoparticles may help treat hair loss by delivering siRNA to target androgen receptors.

Gut bacteria imbalance may cause Post-Finasteride Syndrome symptoms.

Gut bacteria imbalance may cause Post-Finasteride Syndrome symptoms.